SCHEMBL25754734

SCHEMBL25754734

COc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1c(C)cc(Cl)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
IDH1 O75874 1/20 0.52
FFAR4 Q5NUL3 3/20 0.52
NHERF1 O14745 1/20 0.50
MCL1 Q07820 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
TP53 P04637 1/20 0.49
CYTH2 Q99418 1/20 0.48
MAPK1 P28482 1/20 0.47
TBXA2R P21731 2/20 0.47
ALPL P05186 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25754683 0.88 POLB (0.57) POLBFFAR4L3MBTL1ALDH1A1LMNA
SCHEMBL23833774 0.84 POLB (0.56) POLBL3MBTL1ALDH1A1LMNAHPGD
SCHEMBL30199628 0.84 POLB (0.56) POLBL3MBTL1ALDH1A1LMNAHPGD
SCHEMBL25754726 0.84 IDH1 (0.61) POLBIDH1ALDH1A1LMNAHPGD
SCHEMBL25754724 0.81 L3MBTL1 (0.61) POLBNHERF1L3MBTL1ALDH1A1LMNA
SCHEMBL25754679 0.80 SMN1; SMN2 (0.64) POLBIDH1ALDH1A1LMNAHPGD
SCHEMBL25754782 0.80 FFAR4 (0.53) FFAR4ALDH1A1HPGDTP53MAPK1
SCHEMBL4188199 0.79 HPGD (0.66) POLBIDH1NHERF1MCL1L3MBTL1
SCHEMBL25754684 0.79 HPGD (0.62) POLBL3MBTL1ALDH1A1LMNAHPGD
SCHEMBL25754688 0.78 POLB (0.57) POLBIDH1NHERF1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 POLB 1494/4885IDH1 442/4885FFAR4 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.